Illinois General Assembly

  Bills & Resolutions  
  Compiled Statutes  
  Public Acts  
  Legislative Reports  
  IL Constitution  
  Legislative Guide  
  Legislative Glossary  

 Search By Number
 (example: HB0001)
Search Tips

Search By Keyword

Public Act 103-0328


 

Public Act 0328 103RD GENERAL ASSEMBLY

  
  
  

 


 
Public Act 103-0328
 
HB2855 EnrolledLRB103 30901 CPF 57441 b

    AN ACT concerning health.
 
    Be it enacted by the People of the State of Illinois,
represented in the General Assembly:
 
    Section 5. The Lyme Disease Prevention and Protection Act
is amended by changing Section 15 as follows:
 
    (410 ILCS 450/15)
    Sec. 15. Lyme Disease Task Force; duties; members.
    (a) The Department shall establish the Lyme Disease Task
Force to advise the Department on disease prevention and
surveillance and provider and public education relating to the
disease.
    (b) The Task Force shall consist of the Director of Public
Health or a designee, who shall serve as chairman, and the
following members:
        (1) one representative from the Department of
    Financial and Professional Regulation, appointed by the
    Director of Public Health;
        (2) 3 physicians licensed to practice medicine in all
    its branches who are members of a statewide organization
    representing physicians, one of whom represents a medical
    school faculty and one of whom has the experience of
    treating Lyme disease, appointed by the Director of Public
    Health;
        (3) one advanced practice registered nurse selected
    from the recommendations of professional nursing
    associations, appointed by the Director of Public Health;
        (4) one local public health administrator, appointed
    by the Director of Public Health;
        (5) one veterinarian, who must be a practicing Doctor
    of Veterinary Medicine, appointed by the Director of
    Public Health;
        (6) one medical entomologist, appointed by the
    Director of Public Health;
        (7) (6) 4 members of the public interested in Lyme
    disease, appointed by the Director of Public Health;
        (8) (7) 2 members appointed by the Speaker of the
    House of Representatives;
        (9) (8) 2 members appointed by the Minority Leader of
    the House of Representatives;
        (10) (9) 2 members appointed by the President of the
    Senate; and
        (11) (10) 2 members appointed by the Minority Leader
    of the Senate.
    (c) The terms of the members of the Task Force shall be 3
years. Members may continue to serve after the expiration of a
term until a new member is appointed. Each member appointed to
fill a vacancy occurring prior to the expiration of the term
for which his predecessor was appointed shall be appointed for
the remainder of such term. The council shall meet as
frequently as the chairman deems necessary, but not less than
4 2 times each year. Members shall receive no compensation for
their services.
    (d) The Lyme Disease Task Force has the following duties
and responsibilities:
        (1) monitoring the implementation of this Act and
    providing feedback and input for necessary additions or
    modifications;
        (2) reviewing relevant literature and guidelines that
    define accurate diagnosis of Lyme disease with the purpose
    of creating cohesive and consistent guidelines for the
    determination of Lyme diagnosis across all counties in
    Illinois and with the intent of providing accurate and
    relevant numbers to the Centers for Disease Control and
    Prevention;
        (3) providing recommendations on professional
    continuing educational materials and opportunities that
    specifically focus on Lyme disease prevention, protection,
    and treatment; and
        (4) assisting the Department in establishing policies,
    procedures, techniques, and criteria for the collection,
    maintenance, exchange, and sharing of medical information
    on Lyme disease, and identifying persons or entities with
    Lyme disease expertise to collaborate with Department in
    Lyme disease diagnosis, prevention, and treatment.
(Source: P.A. 100-1137, eff. 1-1-19; 101-606, eff. 12-13-19.)

Effective Date: 1/1/2024